Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Ying Lan, Nan Yang, Yirong Wang, Yan Yang, Min Xu & Qin He. (2023) Cost-Effectiveness Analysis of Fixed-Dose Tiotropium/Olodaterol versus Tiotropium for COPD Patients in China. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2093-2103.
Read now
Read now
Yanqing Gong, Qiying Chen & Yin Zhang. (2022) The Role of the Clinical Pharmacist on the Health Outcomes of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD). International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1863-1870.
Read now
Read now
Ying Lan, Nan Yang, Yirong Wang, Yujie Yang, Min Xu & Qin He. (2022) Cost-Effectiveness of Umeclidinium/Vilanterol versus Salmeterol/Fluticasone in Elderly Patients with Chronic Obstructive Pulmonary Diseases in China. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 609-619.
Read now
Read now
Dave Singh, Steve Holmes, Claire Adams, Mona Bafadhel & John R Hurst. (2021) Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3009-3016.
Read now
Read now
Anees ur Rehman, Mohamed Azmi Ahmad Hassali, Sohail Ayaz Muhammad, Shahid Shah, Sameen Abbas, Irfhan Ali Bin Hyder Ali & Ahmad Salman. (2020) The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature. Expert Review of Pharmacoeconomics & Outcomes Research 20:6, pages 661-672.
Read now
Read now
Bhavesh Lakhotia, Ronan Mahon, Florian S Gutzwiller, Andriy Danyliv, Ivan Nikolaev & Praveen Thokala. (2020) Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 787-797.
Read now
Read now
Lirong Liang, Yunxiao Shang, Wuxiang Xie, Julie Shi, Zhaohui Tong & Mohammad S Jalali. (2020) Trends in Hospitalization Expenditures for Acute Exacerbations of COPD in Beijing from 2009 to 2017. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1165-1175.
Read now
Read now
Aidi Zhang, Lianhong Wang, Lu Long, Jin Yan, Chun Liu, Sucui Zhu & Xiaowan Wang. (2020) Effectiveness and Economic Evaluation of Hospital-Outreach Pulmonary Rehabilitation for Patients with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1071-1083.
Read now
Read now
Jing Zhang, Wanzhen Yao, Xuedan You, Tianyi Liu & Yuantao Liu. (2019) Comparative analysis of medical expenditure with nebulized budesonide versus systemic corticosteroids in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease in China. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1195-1207.
Read now
Read now
Meng Li, Fengyan Wang, Rongchang Chen, Zhenyu Liang, Yumin Zhou, Yuqiong Yang, Shengqi Chen, Carolina Oi Lam Ung & Hao Hu. (2018) Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3349-3357.
Read now
Read now
Tian Xiao, Xianfeng Zhou, Yun He, Yue Chen, Hua Qiu, Sheng Zhang, Xianglin Wei, Kang Wu, Xiaonan Ruan, Na Wang & Chaowei Fu. (2017) Pain problems for patients with mild and moderate chronic obstructive pulmonary disease – a community-based study in Shanghai. Journal of Pain Research 10, pages 2247-2252.
Read now
Read now
Articles from other publishers (20)
Le Cai, Xu-Ming Wang, Lan Liu, Yi Zhao & Allison Rabkin Golden. (2023) Socioeconomic differentials of trends in the prevalence and economic burden of chronic obstructive pulmonary disease in rural southwest China. BMC Public Health 23:1.
Crossref
Crossref
Noemia Teixeira de Siqueira Filha, Jinshuo Li, Penelope A. Phillips-Howard, Zahidul Quayyum, Eliud Kibuchi, Md Imran Hossain Mithu, Aishwarya Vidyasagaran, Varun Sai, Farzana Manzoor, Robinson Karuga, Abdul Awal, Ivy Chumo, Vinodkumar Rao, Blessing Mberu, John Smith, Samuel Saidu, Rachel Tolhurst, Sumit Mazumdar, Laura Rosu, Surekha Garimella & Helen Elsey. (2022) The economics of healthcare access: a scoping review on the economic impact of healthcare access for vulnerable urban populations in low- and middle-income countries. International Journal for Equity in Health 21:1.
Crossref
Crossref
Jeong-eun Park, Luying Zhang, Yu-Fan Ho, Ge Liu, Rafael Alfonso-Cristancho, Afisi S. Ismaila & Zafar Zafari. (2022) Modeling the Health and Economic Burden of Chronic Obstructive Pulmonary Disease in China From 2020 to 2039: A Simulation Study. Value in Health Regional Issues 32, pages 8-16.
Crossref
Crossref
Chin-Ling Li, Mei-Hsin Lin, Yuh-Chyn Tsai, Ching-Wan Tseng, Chia-Ling Chang, Lien-Shi Shen, Ho-Chang Kuo & Shih-Feng Liu. (2022) The Impact of the Age, Dyspnoea, and Airflow Obstruction (ADO) Index on the Medical Burden of Chronic Obstructive Pulmonary Disease (COPD). Journal of Clinical Medicine 11:7, pages 1893.
Crossref
Crossref
Jin Zhuang, Hongjian Bai, Jian Sun, Ting Zhang, Jingjing Li, Yanjun Chen, Haiyan Zhang & Qian Sun. (2021) The association between fine particulate matter and acute lower respiratory infections in Yancheng City, China. Environmental Science and Pollution Research 28:43, pages 61723-61731.
Crossref
Crossref
Huan‐Huan Lu, Hui‐Hui Zeng & Yan Chen. (2021) Early chronic obstructive pulmonary disease: A new perspective. Chronic Diseases and Translational Medicine 7:2, pages 79-87.
Crossref
Crossref
Ahmed Salem, Heng Zhong, Mafalda Ramos, Mark Lamotte & Hao Hu. (2021) Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China. BMJ Open 11:4, pages e043664.
Crossref
Crossref
Fen Dong, Ke Huang, Xiaoxia Ren, Shiwei Qumu, Hongtao Niu, Yanyan Wang, Yong Li, Minya Lu, Xinshan Lin, Ting Yang, Jianjun Jiao & Chen Wang. (2021) Factors associated with inpatient length of stay among hospitalised patients with chronic obstructive pulmonary disease, China, 2016–2017: a retrospective study. BMJ Open 11:2, pages e040560.
Crossref
Crossref
John R. Hurst, Tonya Winders, Heinrich Worth, Mohit Bhutani, Kevin Gruffydd-Jones, Daiana Stolz & Mark T. Dransfield. (2020) A Patient Charter for Chronic Obstructive Pulmonary Disease. Advances in Therapy 38:1, pages 11-23.
Crossref
Crossref
Ting Yang, Baiqiang Cai, Bin Cao, Jian Kang, Fuqiang Wen, Wanzhen Yao, Jinping Zheng, Xia Ling, Hongyan Shang & Chen Wang. (2020) REALizing and improving management of stable COPD in China: a multi-center, prospective, observational study to realize the current situation of COPD patients in China (REAL) – rationale, study design, and protocol. BMC Pulmonary Medicine 20:1.
Crossref
Crossref
Marta Erdal, Ane Johannessen, Per Bakke, Amund Gulsvik, Tomas Mikal Eagan & Rune Nielsen. (2020) Incremental costs of COPD exacerbations in GOLD stage 2+ COPD in ever-smokers of a general population. Respiratory Medicine: X 2, pages 100014.
Crossref
Crossref
Suhaj Abdulsalim, Mazhuvancherry Kesavan Unnikrishnan, Mohan K. Manu, Saud Alsahali, Alian A. Alrasheedy, Antony P. Martin, Brian Godman & Abubakr A. Alfadl. (2019) Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India. PharmacoEconomics - Open 4:2, pages 331-342.
Crossref
Crossref
Qiuyue Li, Jingping Sun, Xiaowei Chen, Siling Li, Yan Wang, Chunjie Xu, Jing Zhao, Zhonghui Zhu & Lin Tian. (2020) Integrative characterization of fine particulate matter-induced chronic obstructive pulmonary disease in mice. Science of The Total Environment 706, pages 135687.
Crossref
Crossref
Zijing Zhou, Aiyuan Zhou, Yating Peng, Jiaxi Duan, Yuqin Zeng, Yiyang Zhao, Wei Cheng & Ping Chen. (2020) Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study. Respiration 99:7, pages 606-616.
Crossref
Crossref
Xue-qing Yu, Shu-guang Yang, Han Li, Yang Xie, Jian-sheng Li & Pan Zhang. (2019) Preliminary Study to Evaluate Three Different Treatments on Stable Chronic Obstructive Pulmonary Disease Patients Based on Markov Model. Evidence-Based Complementary and Alternative Medicine 2019, pages 1-16.
Crossref
Crossref
Qian Sun, Cong Liu, Renjie Chen, Can Wang, Jiading Li, Jian Sun, Haidong Kan, Jingyan Cao & Hongjian Bai. (2019) Association of fine particulate matter on acute exacerbation of chronic obstructive pulmonary disease in Yancheng, China. Science of The Total Environment 650, pages 1665-1670.
Crossref
Crossref
Ruo-Xuan Dai, Qing-Hua Kong, Bei Mao, Wen Xu, Ru-Jia Tao, Xiao-Ru Wang, Qing-Yao Kong & Jin-Fu Xu. (2018) The mortality risk factor of community acquired pneumonia patients with chronic obstructive pulmonary disease: a retrospective cohort study. BMC Pulmonary Medicine 18:1.
Crossref
Crossref
Tian Xiao, Hua Qiu, Yue Chen, Xianfeng Zhou, Kang Wu, Xiaonan Ruan, Na Wang & Chaowei Fu. (2018) Prevalence of anxiety and depression symptoms and their associated factors in mild COPD patients from community settings, Shanghai, China: a cross-sectional study. BMC Psychiatry 18:1.
Crossref
Crossref
Tapan Dey, Jatin Kalita, Sinéad Weldon & Clifford Taggart. (2018) Proteases and Their Inhibitors in Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine 7:9, pages 244.
Crossref
Crossref
Xian Wen Sun, Pei Li Chen, Lei Ren, Ying Ni Lin, Jian Ping Zhou, Lei Ni & Qing Yun Li. (2018) The cumulative effect of air pollutants on the acute exacerbation of COPD in Shanghai, China. Science of The Total Environment 622-623, pages 875-881.
Crossref
Crossref